RAP
Click for more information
0.00% 20.5¢ resapp health limited

Ann: Positive Results from Australian Adult Clinical Studies, page-45

  1. bruutz82
    1,528 Posts.
    lightbulb Created with Sketch. 93
    clock Created with Sketch.
    18/12/17
    14:34
    Post #: 29710061
    One in sixty eight suffer from autism and will have an individual device.

    One in 10 suffer from asthma.

    Despite this, RAP's market will predominately comprise of doctors who will utilse the app on behalf of their patient. There are 70,000 GP's in Australia verses 367,000 Australian's who are on the autism spectrum.

    RAP's potential market penetration circa 70,000 GP's X (cost of app? $20??) verses

    *** (name of company I cannot announce) 180,000 X $2865 unit cost.

    Big difference - and it is not in RAP's favor.

    RAP market cap - $56mil
    *** market cap - $20mil
    Last edited by bruutz82: 18/12/17
    RAP Price at posting: 9.3¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

1CG OneClick surpasses 150,000 registered users
right-arrow Created with Sketch.
RIO Rio registers 2% drop in iron ore production in 2nd quarter of 2024
right-arrow Created with Sketch.
EVN Evolution shares up 3% on quarterly results for June showing rise in gold production
right-arrow Created with Sketch.
HIQ HITIQ's sensor-containing mouthguard OK'd by World Rugby specifications board
right-arrow Created with Sketch.
DMP Domino's locks in biggest faller status on Thursday as it closes stores in Asia, Europe
right-arrow Created with Sketch.
WGX Australian foreign investment regulators greenlight Westgold's buyout of Karora
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.